Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polygenic risk for schizophrenia and bipolar disorder in relation to cardiovascular biomarkers

5 May 2023

Abstract excerpt

Individuals with schizophrenia and bipolar disorder are at an increased risk of cardiovascular disease (CVD), and a range of biomarkers related to CVD risk have been found to be abnormal in these patients. Common genetic factors are a putative underlying mechanism, alongside lifestyle factors and antipsychotic medication. However, the extent to which the altered CVD biomarkers are related to genetic factors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder and Treatment
Share to Genetic Associations and Epidemiology
Share to Genetic Syndromes and Imprinting

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37145175
DOI: 10.1007/s00406-023-01591-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polygenic risk for schizophrenia and bipolar disorder in relation to cardiovascular biomarkersPMID 37145175Read ↗

Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits.Semantic proximity Read ↗

Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disordersSemantic proximity Read ↗

The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals.Semantic proximity Read ↗

Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants.Semantic proximity Read ↗

Genetic susceptibility of cardiometabolic outcomes in schizophrenia spectrum disorders.Semantic proximity Read ↗

The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individualsSemantic proximity Read ↗

Characterizing the Shared Genetic Underpinnings of Schizophrenia and Cardiovascular Disease Risk Factors.Semantic proximity Read ↗

Schizophrenia and cardiometabolic abnormalities: A Mendelian randomization studySemantic proximity Read ↗

Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational studySemantic proximity Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study.Semantic proximity Read ↗

Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.